Cidara Therapeutics

Mundipharma and Cidara Therapeutics receive positive CHMP opinion forrezafungin for the treatment of Invasive Candidiasis in adults

The opinion was based on positive results from the pivotal ReSTORE phase 3 clinicaltrial and supported by the STRIVE phase 2 clinical trials and extensive nonclinicaldevelopment programme If approved by the European Medicines Agency (EMA), rezafungin could be the first newtreatment option in over 10 years for patients with invasive candidiasis. 13 October 2023 --...
6310 Nancy Ridge Drive Suite 101 San Diego, CA 92121

(858) 752-6170